Similar Managemnet team as Cornerstone Therapeutics. Ran stock upp to $10 and now stuck under $5. Same old products, no institutional investors, no patented products worth a toot. Should be under $5 soon enough.
no institut. investors? LOL. you're an idiot.
Natroba, a prescription treatment for children four years and older, showed better results than a similar drug, Permethrin, in eliminating infestation without nit combing.